AAS
NEO icon

Ameritas Advisory Services’s NeoGenomics NEO Stock Holding History

Ameritas Advisory Services’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-47
Closed -$730 – 1835
2023
Q1 		$730 Buy
+47
New +$670 ﹤0.01% 2597

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Advisory Services's NEO Position: Q2 2023 in Review

Ameritas Advisory Services sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 47 shares — an estimated $730 sold.

Ameritas Advisory Services first reported a position in NEO in Q1 2023 and held it in 1 quarter. The position peaked at $730 in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Ameritas Advisory Services reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 47 NeoGenomics shares in Q2 2023, an estimated $730.
  • Ameritas Advisory Services first reported a position in NeoGenomics in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's NeoGenomics position peaked at $730 in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.